Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,768 | -3,696 | -17,346 | -12,919 | -8,734 |
| Depreciation Amortization | 15 | 7 | 16 | 8 | N/A |
| Accounts payable and accrued liabilities | 966 | 447 | -794 | -417 | -894 |
| Other Working Capital | 932 | 309 | -932 | -768 | -1,109 |
| Other Operating Activity | 609 | 77 | 4,834 | 3,119 | 2,718 |
| Operating Cash Flow | $-6,246 | $-2,856 | $-14,222 | $-10,977 | $-8,019 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 5,000 | 5,000 | 5,000 |
| Common Stock Issued | 61 | 15 | 33 | 24 | 24 |
| Other Financing Activity | 0 | 0 | -55 | -56 | -56 |
| Financing Cash Flow | $61 | $15 | $4,978 | $4,968 | $4,968 |
| Beginning Cash Position | 21,100 | 21,100 | 30,344 | 30,344 | 30,344 |
| End Cash Position | 14,915 | 18,259 | 21,100 | 24,335 | 27,293 |
| Net Cash Flow | $-6,185 | $-2,841 | $-9,244 | $-6,009 | $-3,051 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,246 | -2,856 | -14,222 | -10,977 | -8,019 |
| Free Cash Flow | -6,246 | -2,856 | -14,222 | -10,977 | -8,019 |